Article
Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours.
Acta neuropathologica communications - 6 Jun 2017
Haque Farhana, Varlet Pascale, Puntonet Julien, Storer Lisa, Bountali Aikaterini, Rahman Ruman, Grill Jacques, Carcaboso Angel M, Jones Chris, Layfield Robert, Grundy Richard G
Abstract excerpt
Missense somatic mutations affecting histone H3.1 and H3.3 proteins are now accepted as the hallmark of paediatric diffuse intrinsic pontine gliomas (DIPG), non-brain stem paediatric high grade gliomas (pHGG) as well as a subset of adult glioblastoma multiforme (GBM). Different mutations give rise to one of three amino acid substitutions at two critical positions within the histone tails, K27M, G34R/V. Several...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
